These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 17688663
21. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death. Grünhage F, Rezori B, Neef M, Lammert F, Sauerbruch T, Spengler U, Reichel C. Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216 [Abstract] [Full Text] [Related]
22. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis. Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD. J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056 [Abstract] [Full Text] [Related]
23. [The prognostic value of end-stage liver disease model in liver cirrhosis]. Zhang JY, Zhang FK, Wang BE, Jia JD, Zhang ST. Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):822-4. PubMed ID: 16316560 [Abstract] [Full Text] [Related]
24. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR. J Hepatol; 2004 Jun; 40(6):897-903. PubMed ID: 15158328 [Abstract] [Full Text] [Related]
26. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis. Corneille MG, Nicholson S, Richa J, Son C, Michalek J, Wolf SE, Stewart R. J Trauma; 2011 Jul; 71(1):6-11. PubMed ID: 21818010 [Abstract] [Full Text] [Related]
28. [Application of Model for end-stage liver disease to predict the prognosis of and curative effect for chronic severe hepatitis]. Liu Q, Liu Z, Wang TL, Zhang LL. Zhonghua Yi Xue Za Zhi; 2005 Jul 06; 85(25):1773-7. PubMed ID: 16253168 [Abstract] [Full Text] [Related]
35. Assessment of a modified Child-Pugh-Turcotte score to predict early mortality after liver transplantation. Raszeja-Wyszomirska J, Wasilewicz MP, Wunsch E, Szymanik B, Jarosz K, Wójcicki M, Milkiewicz P. Transplant Proc; 2009 Oct 06; 41(8):3114-6. PubMed ID: 19857689 [Abstract] [Full Text] [Related]
36. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis. Chaurasia RK, Pradhan B, Chaudhary S, Jha SM. J Nepal Health Res Counc; 2013 Jan 06; 11(23):9-16. PubMed ID: 23787518 [Abstract] [Full Text] [Related]
37. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score. Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M. Eur J Clin Invest; 2009 Jan 06; 39(1):65-71. PubMed ID: 19087131 [Abstract] [Full Text] [Related]
40. Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation. Brandão A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G. Clin Transplant; 2008 Jan 06; 22(5):651-6. PubMed ID: 18549449 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]